Numerion Labs, Inc.
Biotechnology · SAN FRANCISCO, CA
BiotechnologySEC Form D
Numerion Labs, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 19, 2026, reporting $19,794,945 raised toward a $35,000,000 offering.
Incorporated in Delaware and based in SAN FRANCISCO, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Numerion Labs, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Stephen WorlandExecutive Officer · Director
- Izhar WallachDirector
- Robert MittendorffDirector
- Adam SeabrookDirector
- Linda MaxwellDirector
- Mike VarneyDirector
- Yan ZhaoExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised